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Abstract
DNA electrotransfer to muscle tissue yields long-term, high levels of gene expression; showing great
promise for future gene therapy. We want to characterize the novel far-red fluorescent protein Katushka
as a marker for gene expression using time domain fluorescence in vivo imaging. Highly efficient trans-
genic expression was observed after DNA electrotransfer with 100-fold increase in fluorescent intensity.
The fluorescent signal peaked 1 week after transfection and returned to background level within 4 weeks.
Katushka expression was not as stable as GFP expression, which was detectable for 8 weeks. Depth and
3D analysis proved that the expression was located in the target muscle. In vivo bio-imaging using the
novel Katushka fluorescent protein enables excellent evaluation of the transfection efficacy, and spatial dis-
tribution, but lacks long-term stability.
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1. Introduction
In vivo gene delivery is gaining increasing momentum for gene ther-
apy as delivery methods become more advanced and safe. This raises
the need for precise, sensitive, and easy evaluation of gene transfec-
tion efficacy. A method that has become increasingly popular is
whole-bodyimagingoffluorescentproteins(1).Fluorescentproteins
provide unique opportunities for non-invasive labeling and tracking
of transfected cells in living animals in real time (2). Together with
the development of new systems for whole-body imaging, advance-
ments in new fluorescent proteins offer the possibility for direct visu-
alization of gene expression in vivo.
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253For deep tissue imaging, the optical window for favorable light
penetration is in the near-infrared wavelengths (3), which involves
proteinswithemissionspectrainthefar-redwavelengths.Mostpho-
tonsinthevisualspectrumareabsorbedbymelaninandhemoglobin
in animal tissue, while photons with wavelengths longer than
1,100nmareabsorbedbywater.Inaddition,considerablescattering
of the signal occurs at lower wavelengths (3).
Recently, a novel far-red fluorescent, Katushka, was character-
ized(4).ThisproteinwasderivedfromtheseaanemoneEntacmaea
quadricolor, enhanced to perform with higher brightness and
exposedtosite-directedmutagenesistogenerateproteinswithemis-
sion spectra in the far-red region. The resulting Katushka was
reported to be 7- to 10-fold brighter than other far-red fluorescent
proteins, e.g., HcRed and mPlum (4), and is characterized by high
pH stability and photostability (4). Few studies have so far used
K a t u s h k af o ri nv i v ob i o - i m a g i n g( 3, 5, 6), thus in this study we
wantedtocharacterizethepotentialofKatushkaasamarkerforgene
expression, including an evaluation of the kinetics and spatial distri-
bution of the Katushka signal.
Until recent years, the preferred method for detecting fluores-
cence was by use of a charge-coupled device (CCD) camera (1,
7). This approach limits the degree of details one can obtain as
the camera integrates light from the object, resulting in a planar
picture, which is dominated by the light contribution from the
first 1–2 mm of tissue. Using new technology, biological samples
can be excited with sub-nanosecond laser, while emission of indi-
vidual photons is detected using a rapid photon multiplier (PMT).
In this way, the arrival distribution of photons as a function of
time of excitation can be collected from individual points in the
tissue; allowing for precise spatial and time distribution of the
emitted light. One advantage of determining the fluorescence in
real time is a precise determination of the decay time for the mo-
lecular quantum mechanical transition, which is responsible for
light emission. This lifetime is characteristic for different fluoro-
chromes and by filtering light emission by lifetime, one can obtain
a precise measurement, where background luminescence is elimi-
nated. The precisionalsoallowsfor constructionofa 3Dvolumetric
optic tomographic map of the fluorescence.
Our choice of method for gene delivery is DNA electrotrans-
fer. By exposing living cells to short and intense electric pulses,
position-dependent changes in the transmembrane potential are
induced, rendering cells accessible for cDNA entry (8, 9). There
are many reports on successful in vivo DNA electrotransfer to
muscle tissue as reviewed in Mir et al. (9). We performed the
transfer using a combination of one high voltage (HV) and one
low voltage (LV) pulses. A pulse combination, which has proven
highly efficient for muscle tissue (10, 11) and causing minimal ad-
verse effects on the muscle tissue (12, 13).
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vestigate the novel far-red fluorescent Katushka as a marker for
transgenic expression with respect to intensity, lifetime, and spa-
tial distribution, and compare it to the well-known fluorescent
marker GFP.
2. Materials
and Methods
Animals and muscle preparation Allanimalexperimentswere conducted
inaccordancewiththerecommendationsoftheEuropeanConventionfor
the Protection of Vertebrate Animals used for Experimentation. Experi-
ments were performed on 7–9-week-old female C57Black/6 or NMRI
mice of own breeding. Animals were maintained in a thermostated
environment under a 12-h light/dark cycle and had free access to food
(Altromin pellets, Spezialfutter-Werke, Germany)and water. The animals
were anesthetized 10 min prior to electrotransfer or scanning by intra-
peritonealinjectionsofHypnorm (0.4 ml/kg,Janssen Saunderton,Buck-
inghamshire,UK)and Dormicum(2mg/kg, Roche,Basel,Switzerland).
For ex vivo imaging, the animals were killed by cervical dislocation and
intacttibialiscranialis(TC)muscleswithouttendonswereexcisedandim-
mediately scanned.
Plasmid constructs The plasmids, pTagFP635, encoding Katushka
(Evrogen, Russia), and phGFP-S65T, encoding the green fluorescent
protein (GFP) (Clontech, Palo Alto, CA, USA) both under the control
ofaCMVpromoterwereused.DNApreparationswereperformedusing
Nucleobond AX Maxiprep kits (Machery Nagel), and the concentration
and quality of the plasmid preparations were controlled by spectropho-
tometry. Plasmids were finally dissolved in PBS at a concentration of
0.25 µg/µl unless otherwise specified.
In vivo DNA electrotransfer Twenty-microliter plasmid solution was
injected i.m. along the fibers into the tibialis cranialis muscle using a
29G insulin syringe. Plate electrodes with 4-mm gap were fitted around
the hind legs. Good contact between electrode and skin was ensured by
hair removal and the use of electrode gel (Eko-gel, Egna, Italy). The
electric field was applied using the Cliniporator™ (IGEA, Italy) with
the following settings: a high voltage (1,000 V/cm (applied voltage=
400 V), 100 µs) pulse followed by a low voltage (100 V/cm (applied
voltage=40 V), 400 ms) pulse with a 1-s time lag between the pulses.
The Cliniporator™ provided online measurement of voltage and current.
In vivo bio-imaging Mice were anesthetized and placed in a custom-
made bed, which allowed stable and reproducible imaging of the legs.
In vivo scanning was performed using the Optix MX-2 Optical Mo-
lecular Image System (Advanced Research Technologies, Montreal,
Canada), which uses time domain optical imaging. In time domain op-
tical imaging, short pulses of light driven by pulsed laser diodes are used
to illuminate the organism under study and excite fluorescent mole-
cules. Time-of-flight distribution enables depth and concentration to
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Katushka, excitation was performed with a 635-nm (LDH-P-635)
p u l s i n gl a s e ra n de m i s s i o nw a sd e t e c t e dw i t ha6 5 0l o n gp a s sf i l t e r ,
while excitation of GFP was performed with a 470-nm pulsing laser
and emission was detected through a 525-nm band pass filter. The scan
was performed over a Cartesian grid in prioritized raster fashion, and
each scan took on average 5 min.
Data analysis Data analysis was performed using the Optiview 2.2 soft-
ware (ART Advanced Research Technologies Inc., Canada) supplied
with the ART Optix bioimager. The software is used for background
subtraction, lifetime analysis of the fluorochromes, depth and concen-
tration analysis, and generation of 3D images.
The temporal dispersion of fluorescent photons is measured by
time-correlated single photon counting (TCSPC) after excitation of a
fluorophore by laser pulse. Analysis of this temporal dispersion curve—
the fluorescent temporal point spread function (TPSF)—is used to ob-
tain information of the in vivo fluorophore depth, concentration, and
lifetime. Based on the Optix machine settings, the user will be able mea-
sure temporal and spatial distribution of fluorophores in regions in tissue:
the light intensity is measured as a function of arrival time in nanosec-
onds, where the signal from deeper tissues arrives later allowing the esti-
mation of relative concentration difference.
3. Results
3.1. Efficiency
of Katushka
Expression in Muscles
over Time
Electrotransfer of 5 µg of pTurboFP635 (‘Katushka’) plasmid
resulted in a large increase in thei nv i v of l u o r e s c e n ti n t e n s i t y
(mean peak value=18,695±5,242 NC, n=8) from the transfected
muscle (Fig. 1). The Katushka intensity peaked 1 week after elec-
trotransfer, where after it leveled off and returned to background
level within 4 weeks (Fig. 2). To examine the sensitivity of the in
vivo analysis compared with ex vivo scans, the muscles were ex-
cised at 4 weeks and scanned. Even though Katushka expression
could not be detected in vivo, residual Katushka expression was
present in muscles when scanned ex vivo (Fig. 3).
To determine the minimum dose of Katushka plasmid needed
to give detectable fluorescent intensity, we decreased the amount
o fp T u r b o F P 6 3 5t o0 . 5a n d1µ g ,r e spectively. Electrotransfer
with 1.0 µg of plasmid resulted in detectable fluorescent signal
with an intensity of 1,090 NC, proving that as little as 1.0 µg
of Katushka plasmid is detectable by in vivo imaging (data not
shown).
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of Katushka
Expression
After excitation, fluorescent proteins are characterized by a specific
decay time, known as lifetime. Determination of the lifetime
enables recognition of a specific protein by time domain analysis.
Lifetime analysis of the transgenic Katushka signal obtained with-
Fig. 2. Time course of a Katushka intensity (mean±SD) and b Katushka
lifetime (mean±SD) in a scanning series of seven mice following DNA
electrotransfer of 5 µg Katushka plasmid.
Fig. 1. Time course of the intensity of Katushka expression in muscles after DNA electrotransfer. The
left leg was transfected, while the right leg served as untreated control. The picture series was taken
of the same mouse, but is representative of seven mice.
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2.1 ns. This corresponds to the expected lifetime of Katushka
(Fig. 4). In line with the decrease in fluorescent intensity, the life-
time also decreased at 4 weeks after DNA electrotransfer (Fig. 2).
The temporal point spread function (TPSF) at 4 weeks showed a
dual display, indicating that a real yet weak Katushka signal was
mixed with the background signal (data not shown).
3.3. Comparison of
Katushka versus GFP
Expression
To compare the efficacy of Katushka with GFP, which has been
used extensively for imaging, a scanning series comparing the
two was performed (Fig. 5). Again, the fluorescent intensity of
Katushka peaked at 1 week after DNA electrotransfer and
returned to background level within 4 weeks. The same pattern
Fig. 4. Time course of the lifetime of Katushka expression, showing the same muscles as in (Fig. 1).
Fig. 3. Four weeks after DNA electrotransfer, the muscles were scanned in vivo (left image), and then
excised and scanned ex vivo with the same settings (right image).
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after DNA electrotransfer. GFP, however, did not show the same
degree of decrease in fluorescent intensity and the signal remained
detectable for at least 8 weeks. Looking at the lifetime analyses,
Katushka lifetime decreased at 3 weeks after treatment, while
GFP lifetime remained stable for at least 6 weeks (data not
shown).
3.4. 3D Distribution of
Katushka Expression
The time-of-flight imaging acquisition enabled us to determine
the spatial distribution of the fluorescent signal. Through 3D
analysis (Fig. 6) we determined the spatial location of both the
Fig. 5. Comparison of Katushka and GFP expression in muscles after DNA electrotransfer. Intensity
of Katushka or GFP followed over time and the color scale is set to the same range for both
Katushka and GFP. The left leg was transfected, while the right leg served as control. The pictures
are representative of four mice for each gene.
Fig. 6. 3D analysis of Katushka (left panel) and GFP (right panel) expression in muscles 1 week after
DNA electrotransfer. The 3D analysis allows us to determine the spatial distribution of the Katushka
expression, which in this case coincides with the location of the tibialis cranialis muscle.
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transfer. For Katushka, the fluorescent signal was located
0.1 mm from the top of the leg, reaching 5.6 mm down. From
the side of the leg, the fluorescent signal ranged from 1 mm under
the skin to 5 mm inside the leg. The longitude of the fluorescent
signal was 5 mm. GFP expression was approximately located in
the same area. This volume is equivalent to the location of the
tibialis cranialis muscle, which was the intended target for the
DNA electrotransfer.
4. Discussion
Bio-imaging shows great advantages for detection of gene expres-
sion in vivo (1, 14). In this study, we report highly efficient
Katushka expression in muscles after DNA electrotransfer with lit-
tle background expression. As little as 1.0 µg Katushka plasmid is
sufficient for in vivo detection. Due to the favorable light penetra-
tion in the infrared region, precise determination of the spatial ex-
pression in the tissue was possible, and we found the Katushka
signal to be located in the region corresponding to the tibialis cra-
nialis muscle. Compared to GFP, the Katushka signal had signif-
icantly higher peak intensity in the first weeks; however, the signal
was of shorter duration and in vivo detection was lost after
4 weeks.
DNA electrotransfer is a highly efficient method for in vivo
gene delivery with high level and long-term expression of the
transferred genes (15, 16). For in vivo imaging of muscular trans-
genic expression, penetrating and stable signals are needed. In
vivo imaging with Katushka offered high sensitivity and precision
of the signal, but the signal decayed over a few weeks. This shows
that even though the brightness of Katushka is superior to other
far-red fluorescent proteins (4), Katushka is not the optimal mark-
er for long-term expression as is obtained after DNA electrotrans-
fer to muscle tissue. Katushka may prove useful as a marker of
weak gene expression due to the superior brightness. In this
study, the intensity of Katushka was 3-fold higher than GFP at
1 week after DNA electrotransfer.
A particular advantage of time domain optical imaging is the
possibility to determine the spatial distribution of the fluorescent
signal. We found that both Katushka and GFP expression was
good tools in 3D analysis as little background and divergence of
the signal occurred. Based on the geometric positions generated
by the 3D analysis, we were able to give an estimate of the loca-
tion of the fluorescent signal. In the transfected legs, the fluores-
260 P. Hojman et al.cent signal corresponded to the location of tibialis cranialis mus-
cle, which was the intended target of our transfections. Since
we were imaging tissues, which were only 5 mm in depth, we
did not find any significant differences between the two fluoro-
chromes regarding the estimation of the spatial distribution.
Far-red fluorescent proteins should in theory be superior in deep
tissue imaging; however, in our case, the tibialis cranialis muscle
was not located deep enough for this effect to be important.
The initial study describing Katushka proved it highly photo-
stable with fast recovery after bleaching (4). Thus, the weekly
scans, which we performed, should not be bleaching the signal
to a degree that could explain the decrease in intensity, which
we observe in our experiments. Katushka has a fast maturation
time (20 min); however, the half-life in vivo is unknown. Our
studies showed that Katushka has a lower stability in vivo than
GFP. Katushka is a newly described fluorescent molecule and
few studies on the biochemical properties of Katushka exists (4),
thus whether the low stability is due to intrinsic protein features
or whether Katushka might be immunogenic in vivo remains to
be investigated.
In conclusion, time domain optical imaging with intensity,
lifetime, and 3D analyses ensured extensive characterization of
Katushka expression; proving that Katushka offered excellent eval-
uation of the transfection efficacy with a signal much brighter
than GFP. The maintenance of the fluorescent signal was, howev-
er, lost within a few weeks, showing that Katushka is not a good
candidate for long-term detection of in vivo transgenic expres-
sion. Both Katushka and GFP were good markers for the spatial
distribution of gene expression in the tibialis cranialis muscle.
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